相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection
Galit Alter et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive
Natalie A. Hutnick et al.
VACCINE (2010)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
T. Christopher Mast et al.
VACCINE (2010)
IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells
Mark A. Brockman et al.
BLOOD (2009)
Genetic Association of IL-10 Gene Promoter Polymorphism and HIV-1 Infection in North Indians
Animesh Chatterjee et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Incorporation of CD40 Ligand into the Envelope of Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Enhances Immunogenicity
Fan-ching Lin et al.
JOURNAL OF VIROLOGY (2009)
Host Immune Responses to Chronic Adenovirus Infections in Human and Nonhuman Primates
Roberto Calcedo et al.
JOURNAL OF VIROLOGY (2009)
Replication-Defective Adenovirus Vectors with Multiple Deletions Do Not Induce Measurable Vector-Specific T Cells in Human Trials
Richard A. Koup et al.
JOURNAL OF VIROLOGY (2009)
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Jinyan Liu et al.
NATURE (2009)
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans
Kara L. O'Brien et al.
NATURE MEDICINE (2009)
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells
Natalie A. Hutnick et al.
NATURE MEDICINE (2009)
Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1
Adel Benlahrech et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial
Paul Spearman et al.
VACCINE (2009)
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
Sampa Santra et al.
VACCINE (2009)
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
Frances H. Priddy et al.
CLINICAL INFECTIOUS DISEASES (2008)
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection
David G. Brooks et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
Matthieu Perreau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara
Eric Sandstrom et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8+ T cell immunity
Xiao-Li Huang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B
Shuangqing Yu et al.
VACCINE (2008)
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals
Jun Liu et al.
VACCINE (2008)
Systemic and mucosal immunological responses during repeated mucosal SHIV162P3 challenges prior to and following infection in pigtailed macaques
Nattawan Promadej-Lanier et al.
VIROLOGY (2008)
Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity
Elizabeth J. Faul et al.
VIROLOGY (2008)
Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus Ankara-Human immunodeficiency virus vaccine vectors
Xiugen Zhang et al.
JOURNAL OF VIROLOGY (2007)
Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination
Helen Horton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Enhanced rates and magnitude of immune responses detected against an HIV vaccine: Effect of using an optimized process for isolating PBMC
Lisa S. Kierstead et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation
Fusheng Li et al.
VACCINE (2006)
Interleukin-10 determines viral clearance or persistence in vivo
David G. Brooks et al.
NATURE MEDICINE (2006)
Resolution of a chronic viral infection after interleukin-10 receptor blockade
Mette Ejrnaes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells
SC Zimmerli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene:: Application in epidemiologic studies and in the design of adenovector vaccines
M Aste-Amézaga et al.
HUMAN GENE THERAPY (2004)
Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy
A Harari et al.
BLOOD (2004)
Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors
DR Casimiro et al.
JOURNAL OF VIROLOGY (2004)
The innate immune response to adenovirus vectors
DA Muruve
HUMAN GENE THERAPY (2004)
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
S Kostense et al.
AIDS (2004)
Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand
CF Yang et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses
R Youil et al.
HUMAN GENE THERAPY (2003)
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10
HD Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages
K Kedzierska et al.
AIDS (2000)
HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
V Appay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
